Cantitate/Preț
Produs

Biostatistics for Bioassay: Chapman & Hall/CRC Biostatistics Series

Autor Ann Yellowlees, Matthew Stephenson
en Limba Engleză Hardback – 24 dec 2024
In recent decades, there has been enormous growth in biologics research and development, with accompanying development of biological assays for emerging products. In parallel, there have been substantial advances in statistical methodology, as well as technological advances in computer power, enabling new techniques to be implemented via statistical software. Biostatistics for Bioassay presents an overview of the statistical analysis techniques that are needed in order to report the results of biological assays. These assays are needed for testing all biological medicines, such as vaccines and cell therapies, to allow them to be released for use. Beginning with consideration of the performance characteristics required of a bioassay, including accuracy, precision, and combinations of these two attributes, the book builds a framework for statistical bioassay design.   
Features:
  • Explains the statistical methods needed at each stage of the lifecycle of a bioassay
  • Describes the demonstration of the bioassay’s performance, known as validation
  • Covers the statistical techniques for monitoring the bioassay’s performance over time
  • Details how to transfer the bioassay to another laboratory or replace critical reagents
  • Provides examples at every stage, to allow the reader to work through the techniques and consolidate their understanding
The book provides a resource for interested bioassay analysts, and statisticians working with bioassays. In bringing together best practice in statistics across the bioassay lifecycle into a single volume, it aims to provide a comprehensive and useful textbook for statistical analysis in bioassay.
Citește tot Restrânge

Din seria Chapman & Hall/CRC Biostatistics Series

Preț: 65694 lei

Preț vechi: 69152 lei
-5% Nou

Puncte Express: 985

Preț estimativ în valută:
12574 13077$ 10537£

Carte disponibilă

Livrare economică 20 februarie-06 martie
Livrare express 06-12 februarie pentru 42100 lei

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781032579726
ISBN-10: 1032579722
Pagini: 304
Ilustrații: 210
Dimensiuni: 178 x 254 x 25 mm
Greutate: 0.77 kg
Ediția:1
Editura: CRC Press
Colecția Chapman and Hall/CRC
Seria Chapman & Hall/CRC Biostatistics Series

Locul publicării:Boca Raton, United States

Public țintă

Postgraduate, Professional Practice & Development, Professional Reference, and Professional Training

Cuprins

I Potency and its measurement: bioassays and their performance. 1. Introduction - bioassays and potency. 2. Bioassay performance requirements. 3. Bioassay design. II Estimation of potency: the statistical analysis of bioassay runs. 4. Statistical models for characterising the dose-response relationship. 5. Choosing the dose-response relationship for bioassay data. 6. Assay data analysis. 7. Bioassay suitability criteria. III Validation, monitoring and modifications. 8. Qualification and validation of bioassays. 9. Monitoring the performance of a bioassay procedure.10.Bioassay updates and modifications.

Notă biografică

Ann Yellowlees is Founder of Quantics Biostatistics. Ann has worked in academia, Shell Research, and the NHS in Scotland. She has been consulting in bioassay statistics since 2006. She holds degrees in both mathematics and applied statistics from the University of Oxford, and a PhD in statistics from the University of Waterloo.
Matthew Stephenson is a Director of Statistics at Quantics Biostatistics, with an undergraduate degree in human kinetics, and an MSc and PhD in statistics from the University of Guelph. He won the 2020 Canadian Journal of Statistics Award for his PhD research on leveraging graphical structure among predictors to improve outcome prediction. 
 

Descriere

This book is about the statistical analysis techniques that are needed in order to report the results of biological assays. These assays are needed for testing all biological medicines, such as vaccines and cell therapies, to allow them to be released for use.